Literature DB >> 1833123

The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives.

W H Taylor1.   

Abstract

The prevalence of diabetes mellitus in a series of 205 patients with proven primary hyperparathyroidism was 7.8% (16 patients). Eight patients were known to have diabetes at first attendance (prevalence 3.9%), four were discovered at the time of diagnosis of hyperparathyroidism (combined prevalence 5.9%) and four subsequently. Diabetes had been diagnosed from age 39 yr onwards, and in those with diabetes hyperparathyroidism was diagnosed at age 44 yr or later. The prevalence of diabetes in primary hyperparathyroidism is significantly greater than in a series of 200 consecutive non-hyperparathyroid outpatients attending the same unit (3.0%, p less than 0.05), or in the general populations of Oxford and Poole, after matching for age and sex (p less than 0.05), or in the combined populations of Oxford, Poole, and Southall (white population) (p less than 0.05) after similar matching. However, the prevalence of diabetes in hyperparathyroidism did not differ significantly from that of the white population of Coventry, where the prevalence is higher than that of Oxford, Poole and Southall. For hyperparathyroid patients presenting at age 40 yr or over, the prevalence of known diabetes (4.7%) is significantly greater than in the general populations at similar age of Oxford, Poole, and Southall.

Entities:  

Mesh:

Year:  1991        PMID: 1833123     DOI: 10.1111/j.1464-5491.1991.tb01678.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism.

Authors:  F Tassone; L Gianotti; C Baffoni; F Cesario; G Magro; M Pellegrino; I Emmolo; M Maccario; G Borretta
Journal:  J Endocrinol Invest       Date:  2011-12-21       Impact factor: 4.256

2.  Parathyroid hormone is associated with incident diabetes in white, but not black adults: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  J P Reis; E Selvin; J S Pankow; E D Michos; C M Rebholz; P L Lutsey
Journal:  Diabetes Metab       Date:  2016-01-15       Impact factor: 6.041

Review 3.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

Review 4.  Derangement of glucose metabolism in hyperparathyroidism.

Authors:  M Procopio; G Borretta
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

5.  Parathyroid hormone decreases in vivo insulin effect on glucose utilization.

Authors:  A W Saxe; G Gibson; R L Gingerich; J Levy
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333

Review 6.  Vitamin D, the renin-angiotensin system, and insulin resistance.

Authors:  George Rammos; Paraskevi Tseke; Stavroula Ziakka
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

7.  Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism.

Authors:  Merih Baykan; Cihangir Erem; Turan Erdoğan; Arif Hacihasanoğlu; Omer Gedikli; Abdulkadir Kiriş; Mehmet Küçükosmanoğlu; Halil Onder Ersöz; Sükrü Celik
Journal:  Int J Cardiovasc Imaging       Date:  2006-10-12       Impact factor: 2.316

8.  Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms.

Authors:  M Iftekhar Ullah; Gabriel I Uwaifo; William C Nicholas; Christian A Koch
Journal:  Int J Endocrinol       Date:  2009-11-10       Impact factor: 3.257

9.  The relationship between low maternal serum 25-hydroxyvitamin D levels and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency.

Authors:  Sayid Shafi Zuhur; Rumeysa Selvinaz Erol; Idris Kuzu; Yuksel Altuntas
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

10.  The association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South Africa.

Authors:  Jaya A George; Shane A Norris; Hendrik Emmanuel van Deventer; Nigel J Crowther
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.